Table 3
Univariate and multivariate predictors of uncovered and malapposed struts
| Predictors | Odds ratio (95% CI) | p Value |
| Univariate predictors of uncovered struts | ||
| Stent type: ZES | 0.89 (0.84 to 0.93) | <0.001 |
| Lesion type B2 or C | 1.07 (1.01 to 1.13) | 0.03 |
| Acute coronary syndrome | 1.06 (1.01 to 0.13) | 0.03 |
| Diabetes mellitus | 1.05 (0.99 to 0.12) | 0.07 |
| Multivariate predictors of uncovered struts | ||
| Stent type: ZES | 0.87 (0.82 to 0.91) | <0.001 |
| Lesion type B2 or C | 1.10 (1.02 to 1.20) | 0.02 |
| Diabetes mellitus | 1.06 (1.00 to 1.12) | 0.04 |
| Univariate predictors of malapposed struts | ||
| Stent type: ZES | 0.98 (0.97 to 0.99) | 0.01 |
| Minimal luminal diameter before PCI | 0.99 (0.96 to 1.00) | 0.06 |
| Acute coronary syndrome | 1.02 (1.00 to 1.04) | 0.09 |
| Diabetes mellitus | 1.03 (1.00 to 1.05) | 0.09 |
| Multivariate predictors of malapposed struts | ||
| Stent type: ZES | 0.97 (0.95 to 0.99) | 0.005 |
| Diabetes mellitus | 1.03 (1.01 to 1.05) | 0.004 |
-
PCI, percutaneous coronary intervention; ZES, zotarolimus-eluting stent.
